|
| 4-Methyl-3-(trifluoromethyl)benzoic acid Basic information |
Product Name: | 4-Methyl-3-(trifluoromethyl)benzoic acid | Synonyms: | RARECHEM AL BO 0960;MTF-BOA-4ME;4-METHYL-3-(TRIFLUOROMETHYL)BENZOIC ACID;3-TRIFLUOROMETHYL-P-TOLUIC ACID;4-Methyl-3-(Trifluoromethyl)benzoic Acid 3-(Trifluoromethyl)-4-Methylbenzoic Acid;4-Methyl-3-(trifluoromethyl)benzoic acid, 97+%;3-TRIFLUOROMETHYL-4-METHYL BENZOIC ACID,98%;5-Carboxy-2-methylbenzotrifluoride | CAS: | 261952-01-6 | MF: | C9H7F3O2 | MW: | 204.15 | EINECS: | | Product Categories: | Fluorine series;Benzoic acid | Mol File: | 261952-01-6.mol | |
| 4-Methyl-3-(trifluoromethyl)benzoic acid Chemical Properties |
Melting point | 182-186°C | Boiling point | 268.6±40.0 °C(Predicted) | density | 1.345±0.06 g/cm3(Predicted) | storage temp. | Sealed in dry,Room Temperature | solubility | soluble in Methanol | form | powder to crystal | pka | 3.94±0.10(Predicted) | color | White to Almost white | CAS DataBase Reference | 261952-01-6(CAS DataBase Reference) |
Provider | Language |
ALFA
| English |
| 4-Methyl-3-(trifluoromethyl)benzoic acid Usage And Synthesis |
Chemical Properties | Light brown solid | Uses | 4-Methyl-3-(trifluoromethyl)benzoic acid, can be used as an intermediate in the synthesis of Bafetinib (B109050), which is a substituted benzamide derivative structurally related to STI-571 (Imatinib Mesylate). It was identified as highly potent Bcr-Abl kinase inhibitor. It is a COVID19-related research product. |
| 4-Methyl-3-(trifluoromethyl)benzoic acid Preparation Products And Raw materials |
|